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ABSTRACT 
Aim: The aim of the study was to document the oral health status of individuals using 
methamphetamine.  
Introduction: Methamphetamine (TIK) is a highly addictive drug that acts as a 
stimulant for the central nervous system. The clinical picture of methamphetamine 
abuse is termed “Meth Mouth” and can be explained by contributing factors such as 
dry mouth, a poor appetite, consumption of large amounts of soft drinks and poor oral 
hygiene. 
Materials and Methods: A cross-sectional study was conducted at 22 different 
substance addiction treatment centres in the Western Cape.  A questionnaire was 
administered to elicit demographic details, diet, drug addiction, dental status and 
medical history. The aim of the study was to document the oral health status of 
methamphetamine users. The study consisted of a convenience sample of 308 
participants who used methamphetamine as a primary drug of choice. An oral 
examination was performed to measure dental caries status (DMFT) and treatment 
needs.  
Results: The majority was male, unemployed and between 25 and 29 years old. The 
mean duration of drug addiction was 6 years predominantly on a daily basis and 
93.51% by smoking the drug. The mean DMFT was 10 and dental extractions were 
the most common procedure performed at the last dental visit. A significant difference 
was observed between levels of education and the mean number of extractions that 
were required per participant. The duration of exposure to methamphetamine was 
related to the number of decayed, missing and filled teeth. The majority experienced a 
bad taste, stiff facial muscles and a dry mouth when using the drug. Diet included 
large quantities of liquids (mainly beer and soft drinks) and the majority reported 
having a poor appetite. Users brushed their teeth less frequently when using 
methamphetamine. 
Conclusion: Data on harmful effect of methamphetamine on dental health is 
consistent with published reports. Attention should be given to dental caries 
prevention to support users during recovery and to educate those who might be at risk. 
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CHAPTER 1: INTRODUCTION 
 
Methamphetamine is a highly addictive, man-made drug that acts as a stimulant for 
the central nervous system. It is also known as ‘TIK’ because of the noise made when 
the drug is heated in a glass tube. The drug is ingested in various ways. It can be 
swallowed, smoked, ingested nasally or snorted and injected (Goodchild & 
Donaldson, 2007; Shaner, 2002). Methamphetamine use is characterized by a cyclical 
pattern of abuse that is self-sustaining. It is a white powder (odorless and crystalline) 
and dissolves readily in water or alcohol (Figure 1). The drug is readily available, 
easily produced, affordable and highly profitable (Shaner, 2002). 
 
 
 
Figure 1: Crystalline form of methamphetamine 
 
Media reports and scientific literature indicate that there has been a huge increase in 
the prevalence of methamphetamine users globally (UNODC, 2013). Drug-related 
violence affects the operational activities of police officers, teachers and health care 
workers and leads to rising crime rates.  Additionally, there is an increased burden on 
psychiatric institutions due to the neurological and psychological adverse effects of 
methamphetamine abuse.  
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Methamphetamine is a potent central nervous stimulant and is rapidly addictive. It is 
also known by other names such as speed, crystal meth, ice, chalk, poor man’s 
cocaine, fire and crank (Goodchild & Donaldson, 2007).  
Ingredients such ephedrine, pseudoephedrine, lithium, hydrochloric acid, iodine, 
ether, lye, chloroform, Freon, Drano, drain cleaner, battery acid, red phosphorus, 
lighter fluid, lantern fuel, rock salt, dry ice and propane are used to manufacture 
illegal methamphetamine  (Goodchild & Donaldson, 2007; Shaner, 2002). During 
World War II the pharmacological properties of methamphetamine became known 
and many soldiers were given the drug to enhance their performance (Lee et al., 
1992).   
The drug leads to permanent changes in neurological processes, an increase in violent 
behaviour, higher susceptibility to HIV (Morris & Parry, 2006) and consequent 
decreased oral health. The detrimental effect on the teeth maybe related to the 
xerostomia, high acidity of the methamphetamine as well as personal hygiene neglect 
due to the psychotic adverse effects. Methamphetamine abuse also causes severe 
adverse effects on hard and soft intra oral structures and pathological changes. It is 
essential to investigate the diet preference, drug history and dental status of people 
that are using methamphetamine because these risk factors may contribute to poor 
oral health (Shaner, 2002).  
During recent years the number of users of this substance has reached alarming 
figures in the Western Cape in South Africa (Morris & Parry, 2006). In Cape Town a 
dramatic increase in treatment admissions for adolescent methamphetamine abuse 
occurred between 2004 and 2006 (Pluddeman et al., 2008) - approximately 200,000 
(7% of the population) are estimated to be abusers of methamphetamine.  
In 2005, 45% of patients receiving drug treatment in Cape Town (Figure 2) were 
using methamphetamine, making it the main drug of abuse reported at treatment 
centers (Morris & Parry, 2006). While high levels of use have been recorded among 
Coloured women, an increasing trend in use has been observed among Black women 
in Cape Town (Wechsberg et al., 2008). 
 
 
 
 
 
   15 
 
 
 
Figure 2: City of Cape Town (Google Maps, 2013) 
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CHAPTER 2: LITERATURE REVIEW 
 
The use of methamphetamine results in serious physiological and psychological 
effects that are pertinent to the dental profession. The drug is highly addictive and acts 
as a stimulant for the central nervous system and leads to serious health effects such 
as premature labour, birth defects, memory loss, aggression, psychotic behavior and 
potential heart and brain damage. It also has devastating effects on oral health 
(Goodchild & Donaldson, 2007). It can be snorted, smoked, swallowed or injected 
and the drug’s effects can be experienced within 20 minutes (Schepers et al., 2003). 
This review aims to document the effects of methamphetamine on the oral cavity.  
 
The number of methamphetamine users is estimated at 35 million worldwide 
(Hamamoto & Rhodus, 2009). From 1992 to 2002 admissions for treatment of 
methamphetamine abuse increased more than 500% in the US (Lineberry & 
Bostwick, 2006).   
 
The South African Community Epidemiology Network on Drug Use (SACENDU) is 
a sentinel surveillance project operational in all nine provinces and monitors alcohol 
and drug use on a 6-monthly basis. The proportion for methamphetamine being the 
most common primary drug of addiction has dropped since 2009 (41% to 34%).  
Regarding the proportion of patients that are 20 years and younger, a decrease was 
observed from 51% to 48% for the period 2009 – 2010 (Pluddeman & Parry, 2010). 
In the Western Cape, a third of all patients in treatment rehabilitation centres reported 
using methamphetamine as the primary substance of abuse (Dada et al., 2013).   
 
2.1 Risk factors associated with methamphetamine use 
 
General risk factors for methamphetamine abuse include unstable family 
environment; psychiatric conditions (Kosten & Owens, 2005) and history of violence 
(Russell et al., 2008). Weight loss could be a factor in female use of 
methamphetamine, while increased libido and sexual performance is considered a 
motivating factor for males (Buxton & Dove, 2008).  
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Methamphetamine is also used as a coping strategy by homeless street youth, since it 
acts as an appetite suppressant, enables them to cope with negative emotions and 
helps them to stay awake to protect their belongings (Buxton & Dove, 2008). This is 
of particular relevance to the socially disadvantaged youth in the Western Cape. 
 
2.2 General effects  
 
Use of methamphetamine leads to increased energy, a sense of enhanced physical 
prowess, mental alertness, euphoria and mood elevation.  Dehydration occurs due to 
elevated metabolism and increased physical activity. It also acts as an appetite 
suppressant (Shaner, 2002). 
 
2.3 Physiological effects 
 
The chemical structure is very similar to dopamine and norepinephrine as it causes the 
release of these neurotransmitters into the synaptic cleft (Goodchild & Donaldson, 
2007; Shaner, 2002). The duration of action of methamphetamine is generally 8–12 
hours but can be up to 24 hours during intoxication (O’Brien & Gardner, 2005). 
Dehydration occurs due to an elevated metabolism and increased physical activity. 
The drug also acts as an appetite suppressant. Abuse of the drug causes significant 
morbidity including fatal kidney and lung disorders, hyperthermia, stroke and cardiac 
arrest (Shaner, 2002). It also has an anorexic effect (Goodchild & Donaldson, 2007; 
Shaner, 2002) and causes unexplained motor activity and skin lesions (Richards & 
Brofeldt, 2000). 
 
2.4 Behavioural effects 
 
Users display violent, aggressive and paranoid behaviour during times of using 
methamphetamine (Richards & Brofeldt, 2000) and loss of interest in personal 
hygiene (Shaner, 2002).  
According to the proposed ‘gate-way hypothesis’ by Kandel et al., (1992) the 
progression to illegal substance usage among males is dependent on prior alcohol 
consumption and in females the use of either usage of cigarettes or alcohol is an 
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adequate condition for progression to marijuana. Other strong predictors of further 
progressions are the young age of onset and frequency of use (Yen et al., 2005).   
 
Methamphetamine users have a higher tendency of consuming large amounts of 
carbonated beverages with sugar and tobacco compared to non-users (Morio et al., 
2008).   
 
A significant association between methamphetamine use and sexual risk behaviour 
was found (Pluddeman et al., 2008a) in which it was consistently associated with HIV 
risk behaviours, indicating a high vulnerability to HIV infection. 
 
Skin lesions  formication are due to compulsive picking or “tweaking” at “meth bugs” 
resulting from methamphetamine-induced delusional parasitosis (Buxton & Dove, 
2008; Lineberry & Bostwick, 2006). Self-injurious behaviour is considered as an 
indication of the long-lasting neurotoxicity induced by methamphetamine (Kita et al., 
2008). 
 
2.5 Psychological effects 
 
Methamphetamine is highly psychologically addictive (Heng et al., 2008; Shaner, 
2002) leading to severe depression and suicidal tendencies during withdrawal, with 
permanent psychological problems resembling paranoid schizophrenia (Shaner, 
2002).  
 
Users of methamphetamine are particularly at risk for developing a state of psychosis 
(McKetin et al., 2006). Users display violent, aggressive and paranoid behaviour 
(Richards & Brofeldt, 2000; Shaner, 2002) and loss of interest in personal hygiene 
(Shaner, 2002).  
 
Methamphetamine increases sympathetic activity in the central nervous system, 
causing a reduction in saliva secretion by stimulation of inhibitory alpha-2 receptors 
resulting in reduction in salivary secretion (Goodchild & Donaldson, 2007). 
 
 
 
 
 
   19 
 
 
2.6 Neurological effects 
 
The structural brain changes due to methamphetamine abuse are associated with acute 
and chronic cognitive impairments (e.g. recall and recognition) as well as emotional 
deficits (e.g. depression, psychotic symptoms and anxiety). Only partial improvement 
occurs with abstinence (Wang et al., 2004).  Neurotoxicity and nervous system 
degeneration are associated with long-term use of methamphetamine (Russell et al., 
2008). 
 
2.7 Treatment of methamphetamine addiction 
 
Cognitive-behaviour therapy and contingency management are two psychological 
interventions considered effective in the reduction of methamphetamine use (Lee & 
Rawson, 2008). The Matrix model also produced good results during treatment. 
However these approaches have failed to show long-term benefits (Buxton & Dove, 
2008).  
 
The aim is to protect the brain from the adverse effects of long-term 
methamphetamine use. Vaccines could facilitate recovery from addiction by 
providing long-lasting protection from the rewarding and reinforcing effects of the 
drug (Gentry et al., 2009; Kosten & Owens, 2005). 
 
2.8 Effects on the oral cavity 
 
The clinical picture of methamphetamine abuse (Figures 3 – 7) includes generalized 
caries, periodontal disease, mucosal dysplasia, xerostomia, tooth wear and tooth loss 
(Goodchild & Donaldson, 2007). 
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Figure 3: Close-up anterior view maxillary and mandibular incisors 
 
 
 
 
Figure 4: Right lateral view of maxillary and mandibular molars 
 
 
 
Figure 5: Left lateral view of the maxillary and mandibular molars   
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Figure 6: Occlusal view of the maxillary arch 
 
 
 
 
Figure 7: Occlusal view of the mandibular arch 
 
 
Methamphetamine users have more decayed and missing teeth compared to non-users 
(Cunningham et al., 2011). The drug may lead to poor oral hygiene, xerostomia (dry 
mouth), severe adverse effects on hard and soft intra oral structures and pathological 
changes. Rampant caries caused by high sugar intake due to increased consumption of 
soft drinks in the absence of protective saliva is observed in patients who abuse 
methamphetamine (Shaner, 2002; Klasser & Epstein, 2006; Morio et al., 2008 
Goodchild & Donaldson, 2007). Methamphetamine-related dental destruction may be 
due to a number of interacting factors, namely, rampant decay, the acidity of the drug, 
hyposalivation, an increase in consumption of sugar-containing beverages, poor oral 
hygiene and bruxism (Goodchild et al., 2007). Bruxism as a result of drug-induced 
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hyperactivity causes accelerated tooth wear (Goodchild & Donaldson, 2007). Other 
symptoms are temporomandibular joint (TMJ) disorders, myofacial pain and trismus 
(Heng et al., 2008). 
 
A specific caries pattern known as “Meth Mouth” is observed in patients who abuse 
methamphetamine (Figure 8). The buccal smooth surfaces at the cemento-enamel 
junction and interproximal surfaces of anterior teeth are affected (Shaner, 2002). 
Teeth are darkly stained and crumbled (Heng et al., 2008). Users have a higher 
percentage of anterior teeth, premolars and molars with decay than non-users (Morio 
et al., 2008). The cementum is less resistant to demineralization than enamel; 
therefore, caries starts at the cemento-enamel junction (CEJ) and undermines the 
whole tooth leading to Class V caries in users of methamphetamine (Heng et al., 
2008). Typically, decay occurs on the facial and cervical areas of both the maxillary 
and mandibular teeth with eventual progression to frank coronal involvement 
(Goodchild & Donaldson, 2007). 
 
 
 
Figure 8: “Meth Mouth”  
 
Users who snort methamphetamine have significantly higher tooth wear in the 
anterior maxillary teeth than those who inject, smoke or ingest the drug. Distinct 
patterns of wear based on the route of administration have been observed. Chronic 
vasoconstriction of the arteries supplying the anterior maxillary teeth from frequent 
methamphetamine snorting potentially leads to decreased arterial blood supply to this 
region (Richards & Brofeldt, 2000). 
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It is understood that smoked methamphetamine containing phosphoric, sulfuric, or 
muriatic acid will bathe the teeth in acid and contribute to enamel erosion and 
breakdown (Goodchild & Donaldson, 2007). Rampant caries and tooth fracture leads 
to excessive tooth wear, multiple tooth loss and edentulism (Hamamoto & Rhodus, 
2009). 
 
2.9 Meth Mouth symptoms 
 
The sympathomimetic effect of methamphetamine causes the inhibition on saliva 
secretion which leads to a dry mouth called xerostomia. The alpha-adrenergic 
receptors of the vasculature in salivary glands are stimulated and lead to 
vasoconstriction of blood vessels which causes a reduction in saliva secretion (Shaner, 
2002). Xerostomia (Goodchild & Donaldson, 2007; Hamamoto & Rhodus, 2009; 
Shaner, 2002) contributes to inflammation and other fungal infections, such as 
candidiasis, cheilitis and glossitis (Heng et al., 2008). The patient is at an increased 
risk of dental caries due to a reduction in saliva secretion (Macknelly & Day, 2009). 
Difficulty with mechanical cleaning of the mouth and a decrease in salivary 
antimicrobial protein may follow xerostomia. Speaking and swallowing food can 
become extremely difficult and the patient is more susceptible to oral disease with 
accompanying unpleasant tastes and burning mouth symptoms (Vidović Juras et al., 
2010). Food intake can also be adversely affected by a sore mouth (Macknelly & Day, 
2009).      
 
Methamphetamine users are prone to consume large amounts of soft drinks, to quench 
their thirst, and food containing high sugar levels to maintain high energy levels 
(Brand et al., 2008; Shekarchizadeh, 2013.  The cariogenic properties of soft drinks 
can be explained by the high levels of sugar which are broken down by intra-oral 
bacteria (Richards & Brofeldt, 2000). Poor oral hygiene causes plaque to accumulate 
and then bacteria continue to metabolize the sugar into acids causing demineralization 
of tooth structure (Heng et al., 2008). During periods of high intake of soft drinks and 
sweet food, the oral pH level drops below the critical oral pH point (5.5) and erosion 
and decay of tooth structure usually follows (Grobler, 2011). 
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2.10 Oral health management 
 
Research results from case-control studies indicated that the oral health status of 
methamphetamine users were worse than that of non-users. Recognition of the 
symptoms of “Meth Mouth” (association of rampant caries with methamphetamine 
abuse) can enable the clinician to identify such drug abuse (Shaner, 2002). The 
unusual caries appearance (multiple cervical cavities) should alert the clinician to the 
fact that the patient may be abusing methamphetamine. 
 
The patient should be referred to a physician or substance abuse rehabilitation centre. 
Furthermore, dentists may be instrumental in identifying the oral signs and symptoms 
associated with methamphetamine abuse (Goodchild et al., 2007). Therefore they 
need to be aware of the clinical presentation and medical signs presented by patients 
who are methamphetamine users (Hamamoto & Rhodus, 2009). 
 
The approach to oral health management needs to be multidisciplinary with specific 
emphasis on prevention, promotion, restoring teeth and restoring/improving salivary 
gland function. Regular oral health instruction and education in combination with a 
determination of patient adherence and participation will shape the core oral health 
management plan for patients who have a history of methamphetamine addiction 
(Hamamoto & Rhodus, 2009). The main objective of treatment is to reduce 
development and progression of dental caries and improve salivary flow. It could also 
be beneficial for the patient to consult a dietician because the literature suggests that 
methamphetamine addicts develop a craving for consumption of soft drinks and are 
known for having a poor appetite which may lead to malnutrition and dietary 
insufficiencies (Hamamoto & Rhodus, 2009). 
 
2.10.1 Diet and oral hygiene habits 
 
The most important aspect of management is to encourage the patient to stop the habit 
of using methamphetamine. They need to be informed that the continued use of the 
drug will result in severe dental as well as neurological and other complications that 
will be difficult to treat. Patients need to be informed that the consumption of 
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carbonated drinks and food containing high levels of sugar should be reduced 
immediately. Improved oral hygiene and a balanced diet will also contribute to the 
dental rehabilitation. Patients need to be encouraged to actively take care of their oral 
health i.e. brushing twice per day with a soft tooth brush, flossing on a regular basis 
and to make use of a fluoridated tooth paste (Macknelly & Day, 2009). 
 
2.10.2 Fluoride 
 
Regular fluoride applications are essential to reduce dental caries progression. Oral 
rinses containing low levels of fluoride that do not require prescription may not be 
sufficient and professionally applied fluoride is strongly advised. Due to the 
unpleasant taste of stannous fluoride, as well as the potential burning sensations it 
may cause in the patient with xerostomia, the preferred mouth rinse is a solution of 
sodium fluoride (Goodchild & Donaldson, 2007). 
 
2.10.3 Xerostomia 
 
Methamphetamine users are xerostomic and therefore the pH of the mouth remains 
acidic for longer periods. Being xerostomic, the buffering capacity of saliva is 
reduced (Heng et al., 2008).  
 
Saliva contains secretory IgA which is an essential component of the immunological 
defense mechanism in the oral cavity (Rhodus, 1997). 
 
The patient should be advised to drink 8 to 10 glasses of water each day and should 
avoid the consumption of caffeine, tobacco and alcoholic beverages because of their 
diuretic effects (Rhodus and Bereuter, 2000).  Patients should also be encouraged to 
rinse their mouths on a regular basis (every hour) with 0.9% saline solution which is 
available at pharmacies (Macknelly & Day, 2009). 
 
Other options include salivary substitutes, oral moisturizers and artificial saliva. 
However, the active agent in these products (carboxymethycellulose or 
hydroxymethylcellulose) does not improve the viscosity of saliva and their actions are 
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of short duration, resulting in only minor relief when compared to water (Rhodus, 
1997). Saliva substitutes may decrease the dental plaque index as well as a lower risk 
of developing gingivitis and fungal infection (Montaldo et al., 2010).   
 
The pharmacalogical stimulation of the salivary glands by using Pilocarpine is 
another possible method to relieve xerostomia. Pilocarpine is an alkaloid, 
parasympathomimetic drug taken from the Pilocarpus plant and acts as a muscarinic-
cholinergic agonist and it is responsible for the stimulation of smooth muscle and 
exocrine glands such as the minor and major salivary glands for increased saliva 
secretion (Macnelly & Day, 2009). Recommended dosages are ranging from 2.5 to 
15mg, 2 to 6 times per day per os (Fox et al., 1991).  
 
Major salivary glands can also be treated with low intensity laser BTL2000 on 
multiple occasions. Significant results from a previous study revealed higher 
salivation activity as well as increased levels of IgA (Vidović Juras et al., 2010). 
 
2.10.4 Pain 
 
Patients often seek dental care due to severe dental pain. They experience pain 
between drug binges or after they have decided to stop methamphetamine abuse 
(Laslett & Crofts, 2007). A thorough history, examination of the source of the main 
complaint as well as the present oral status is essential during oral examination 
(Hamamoto & Rhodus, 2009).     Local anaesthetics containing vasoconstrictors 
should be avoided in the case of a patient who took methamphetamine less than 24 
hours prior to the dental visit as it may result in cardiac dysrhythmias, myocardial 
infarction, and cerebrovascular accidents (Turnipseed et al., 2003; McGee et al., 
2004).  
 
In addition, special caution also should be taken before prescribing medication to drug 
addicts due to potential harmful interactions in the case of a patient who is already 
using other drugs e.g. opioids. Health professionals should also not make use of 
prewritten prescription forms because methamphetamine users can demand on pain 
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medication when they refuse to receive clinical treatment. Non-steroidal anti-
inflammatory drugs are safe to prescribe (Laslett & Crofts, 2007). 
 
2.11 Preventive measures 
In summary, the following preventive measures could be used (Goodchild & 
Donaldson, 2007): 
 Stimulating saliva flow by means of pharmacologic agents   
 Salivary substitutes 
 Chewing sugarless gum (the simplest and most likely method to ensure client 
compliance).  
 Oral moisturizers 
 Increasing fluoride exposure to the oral cavity by administering a neutral 
fluoride (Sodium fluoride 1.1%) to buffer the pH and aid in caries prevention.  
 Professionally applied Fluorides in trays, gels, rinses or varnishes could be 
used  
 Increasing consumption of water and reduce intake of sugary drinks 
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CHAPTER 3: AIM & OBJECTIVES 
3.1 Aim  
 
The aim of the study was to determine the oral health status of individuals using 
methamphetamine 
 
3.2 Objectives 
 
To determine the: 
1.  Demography of  methamphetamine users  
2.  History of methamphetamine use  
3.  Dietary habits of methamphetamine users  
4.  Perception  of the oral health risks associated with drug abuse 
5. Dental caries status of methamphetamine users  
6. Brushing frequency of methamphetamine users  
7. Oral symptoms associated with methamphetamine use 
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CHAPTER 4: MATERIAL & METHODS  
 
The present study utilized two instruments. Firstly, a researcher-administered 
questionnaire was used to elicit demographic information, history of drug use, 
medical history and dental history and secondly a data capture sheet was used 
following the clinical examination of the oral cavity to determine the dental caries 
status and treatment needs.  
 
4.1 Study design 
 
The study design was cross-sectional and descriptive in nature. 
  
4.2  Study sites  
 
Twenty two (22) substance abuse centres in the Western Cape (Figure 2) were 
included in the study.  
 
 
Figure 9: Geographical area of treatment centres (Google Maps, 2013) 
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4.3 Study population 
 
The study population consisted of individuals who were using methamphetamine as a 
primary substance of abuse and who were in a treatment programme at a substance 
abuse treatment centre in the Western Cape.    
 
4.4 Study sample 
 
A convenience sample (n = 308) of methamphetamine users were included in the 
study. 
 
4.5 Instrument 
 
A structured researcher administered questionnaire was used to collect data on 
demographic information, history of drug use, diet and dental history (Appendix 1).  
Oral health symptoms during drug use such as grinding teeth, tooth ache, stiff facial 
muscles, sore gums, burning mouth and dry mouth were also investigated. 
 
An intra-oral clinical examination was performed to measure the dental caries status 
(Decayed, Missing and Filled Teeth) and to determine treatment needs. The WHO 
Oral Health Survey guidelines and criteria for determining DMFT were used (WHO, 
2013). The oral examination was carried out using a plane mirror and dental curved 
probe, no radiographic examinations were performed. Supplies and the examination 
area at each treatment centre adhered to the requirements initiated by the World 
Health Organization (WHO, 2013). 
 
Information on the Decayed, Missing and Filled Teeth Index (DMFT) was captured 
on a data capture sheet (Appendix 2). The D-component included all teeth with codes 
1 or 2. The M-component included teeth coded 4 in patients under 30 years of age and 
the teeth coded 4 or 5 for patients who are 30 years and older, i.e. missing due to 
caries or for any other reason. The F-component included only teeth with code 3. 
Teeth coded 6 (fissure sealants) or 7 (bridge abutment, special crown or 
veneer/implant) were not included in calculation of the DMFT. 
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DMFT index was calculated by dividing the total number of decayed, missing and 
filled teeth by 28.  
 
4.5.1 Developing the study questionnaire 
 
A pilot study was conducted to test the questionnaire in terms of practicability and 
relevance. A convenience sample was selected (n=15) from patients who were self-
reported methamphetamine users who presented at the Tygerberg Oral Health Centre 
and the Out-Patient Department of Stikland Psychiatric Hospital.   
The pilot study was carried out to: 
1. test the suitability of the method of collecting the data 
2. test how long each examination will take to complete 
3. check the adequacy of the data capture sheet 
4. check that all the parameter measurements are clear and unambiguous 
5. ensure that no major item has been omitted  
6. remove any items that do not yield usable data 
 
4.5.2 Preparation for the final draft  
 
After the pilot study, irrelevant and problematic items were identified and deleted or 
reformulated. A final draft of the questionnaire was then printed and used for the final 
study sample.  
 
4.6 Data collection   
 
Information was retrieved from the completed questionnaires and transferred to a 
spread sheet in Microsoft Excel 2010. The collected data was categorized, coded and 
entered into the computer.  
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4.7 Validity 
 
Control for confounding variables was taken into consideration by including the 
medical history and medication of participants. Users who were on medication that 
could lead to a dry mouth were excluded from the study.  
 
The author was the only investigator involved in the gathering of data. Interpretation 
of data and statistical analysis was done by the author and an independent statistician. 
To ensure validity, the questionnaire was subjected to a test-retest procedure.       
 
4.8 Reliability 
 
Prior to measurement, the investigator was calibrated by two independent researchers 
to ensure uniformity of the oral examination. A kappa statistic of 0.873 was obtained, 
indicating good agreement (Appendix 3). 
 
4.9 Data analysis 
 
4.9.1 Description 
 
A basic descriptive analysis was done using the Microsoft Excel and Epi Info (version 
7). The database was imported into Epi Info 7 ® and R ® to perform more complex 
statistical analyses.  
 
The independent t-test was used to determine the association between variables. The 
Mann-Whitney U test was used to determine the association between nominal and 
ordinal variables. Chi-square tests were used for other associations. Statistical level 
significance was set at p < 0.05. 
 
4.10 Establishing contacts  
 
Access to the participants of the study was made initially by a letter to each treatment 
facility manager (Appendix 4).  An introduction of the researcher, the basic aims and 
objectives of the study, what participating in the study would involve and how long 
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the examination and questionnaire would take were explained. It was emphasized that 
that strict confidentiality would be maintained at all times and that the results of the 
study would be presented in a manner that ensured anonymity. Once signed informed 
consent (Appendix 5) was received from each participant, appointments were made 
and the patients interviewed and examined.   
 
4.11 Ethical considerations 
 
The research proposal was approved by the Senate Research Ethics Committee of the 
University of the Western Cape on the 23
rd
 of July 2010 (ID number: 10/05/17).  
Further research approval was also obtained from the Western Cape Department of 
Social Development on the 30
th
 November 2012 (ID number: 9/2/114/3/2/4) and The 
City of Cape Town on the 12
th
 of December 2012 (ID number: 10331). Participation 
was voluntary and anonymous and signed informed consent was obtained from each 
patient. Anonymity was secured by not using the participant's names on the 
questionnaire and the questionnaire was recorded with reference codes. A separate 
consent form (Appendix 6) was signed if photographs were taken. Interviews and oral 
examinations took place in a private room at the treatment centre.   
 
4.11.1 Collaborative partnership 
 
In order to obtain access to the selected participants a good relationship was 
established between the principal investigator and the directors of the various 
treatment centres. Meetings with the director of each substance abuse centre prior to 
participant selection ensured a level of trust and consideration. During these meetings 
the study was explained in detail regarding the objectives, aim and methodology. An 
opportunity was created for questions to be asked and to ensure proper understanding 
of the study.  
 
4.11.2 Social value 
 
Beneficiaries of the research were firstly the participants who received a free dental 
consultation by a qualified dentist that included essential oral health education and 
instructions.  
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By incorporating oral health services into their existing programme, drug addiction 
centres can benefit from the study being able to provide more comprehensive care to 
their clients. 
 
4.11.3 Informed consent 
 
Signed informed consent has been obtained from all participants after they were fully 
informed of the aim, objectives and methodology of the study. Participants were able 
to ask questions and were informed that they could withdraw from the study at any 
stage during the interview and examination.  
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CHAPTER 5: RESULTS 
 
This chapter reports on the findings of a cross-sectional study that investigated the 
oral health status of methamphetamine users involved in a treatment programme. Self-
reported data was collected on demography, history of abuse, dietary habits, oral 
health symptoms which were experienced during abuse and brushing frequency. 
Clinical examination provided information on dental status and treatment needs and 
the association between DMFT and duration of addiction.  
 
5.1 Response rate 
 
Twenty two (22) substance abuse treatment centres were visited and the sample size 
was 308 participants. More than a quarter of the sample (26.62%) was from centres in 
the Tygerberg sub-district of the City of Cape Town and 22.4% from centres outside 
the borders of the City of Cape Town.  
 
5.2 Demographic information  
 
5.2.1 Gender  
 
The majority of the sample was male (69%).   
 
5.2.2 Age distribution 
 
The mean age of the sample was 27 (SD = 6.7) years. The median for age was also 27 
indicating that age was normally distributed. The inter quartile range for age was 22 – 
30. Half were aged between 21 – 29 years old (Figure 10).  
 
The mean age of male users was 26 year and for female users the mean age was 28 
years, with  no statistical significant  difference (p = 0.09). The youngest user in the 
study was a 15 year boy and the oldest, 48 years old.     
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Figure 10: Categorical age distribution of study sample   
 
5.2.3 Employment status  
 
The unemployment rate was 71.57% and the mean duration of unemployment was 21 
months. The most common occupations were craft and trade workers, service and 
sales workers and elementary occupations.    
 
5.2.4 Level of education 
 
Only a fifth (20%) had received tertiary education. The majority (72.40%) of users 
indicated high school and 6.17% primary school as the highest level of education 
(Figure 11).  
 
  
 
Figure 11: Highest level of education reached 
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5.2.5 Other demographic information 
 
More than half of the sample had children (58.5%) with a mean of two children per 
person.  Almost half (45%) of all females who were mothers was pregnant before the 
age of 20. The majority (85%) were not married on the day of the interview.  
 
5.3 Drug abuse history 
 
5.3.1 Age at first use 
 
A third of the sample reported that they were 16 years and younger when they started 
using methamphetamine. The mean age at first usage of methamphetamine among the 
entire sample was 20 (SD = 6.5) years old.  There was a significant difference (p = 
0.02) between males and females with regards to age of first usage (males started at 
the age of 19 years, females at age 21 years).  
 
5.3.2 Duration of drug addiction 
 
The mean duration of drug addiction was approximately 6.5 (SD = 3.1) years. The 
mode for duration of addiction was 7 years. More than two thirds used the drug for 
more than 4 years (Table 1).    
 
Table 1: Categories of duration of addiction 
 
DURATION OF ADDICTION n % 
0 – 4 years 98 31.82 
5 – 8 years  131 42.53 
More than 8 years  79 25.65 
Total 308 100.00 
 
5.3.3 Frequency of drug use 
 
The majority of the sample reported using methamphetamine on either a daily 
(73.38%) or a weekly (23.38%) basis (Table 2). 
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Table 2: Frequency of drug use 
 
FREQUENCY OF DRUG USE  n % 
Everyday 226 73.38 
Weekly 72 23.38 
Monthly 10 3.25 
Total 308 100.00 
 
 
5.3.4 Method of drug use 
 
The majority (93%) of the sample reported smoking as the primary method of using 
methamphetamine. Ten patients (3.25%) reported of snorting the drug, nine (2.92%) 
drank it and one person (0.32%) injected the drug (Table 3).  
 
Over 60% indicated that they were using methamphetamine with others.   
 
Table 3: Method of usage 
 
METHOD OF USAGE  n % 
Smoke 288 93.51 
Snort 10 3.25 
Drink 9 2.92 
Inject 1 0.32 
Total 308 100.00 
 
 
5.3.5 Number of days since the last usage (abstinence) 
 
The mean duration since last usage was 70.33 days. About 12% indicated that they 
had not used methamphetamine in the past 21 days.    
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5.3.6 Daily expenditure  
 
The average daily expenditure on methamphetamine per person was R166.30 and 
there was no significant difference between users were employed and those who were 
unemployed (p = 0.44).  
 
5.3.7 Participant’s first introduction of the name “Tik” (methamphetamine) 
 
The majority (70.45%) of participants reported that they were informed about 
“Tik/methamphetamine” for the first time from friends and 16.23% heard about it 
from family (Table 4).    
 
Table 4: First introduction of the word: “Methamphetamine or Tik”  
 
WHERE DID YOU HEAR OF TIK FOR THE FIRST TIME? n % 
Radio 1 0.32 
University 1 0.32 
Newspaper 6 1.95 
TV 7 2.27 
Other 10 3.25 
School 16 5.19 
Family 50 16.23 
Friends 217 70.45 
Total 308 100.00 
 
5.3.8 Reasons for using methamphetamine 
 
The majority (61.12%) reported that “experimenting” was the reason for first using 
the drug. Peer pressure (17.28%), home issues/problems (9.3%), emotional 
trauma/problems (4.32%) and being in a relationship with a methamphetamine user 
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(2.66%) were other reasons. Five (1.62%) users reported that they started using the 
drug to lose weight.   
 
5.4 Dietary habits 
 
5.4.1 Drinks and food types preferred 
 
Nearly two thirds (59.09%) reported consuming large amounts (2 – 6 l/day) of soft 
drinks and 45.78% consumed alcohol drinks while using the drug. More than half of 
the sample also drank water (55.19%) because it was free and quenched the severe 
thirst after using the drug.      
 
 “Food” consisted mainly of chocolates and sweets (18.18%) and “junk food” / take-
away (15.58%).  Other food consumed included crisps and salty snacks (13.31%), 
bread and pasta (12.99%), breakfast cereal & porridge (11.04%), and fruit and 
vegetables (9.42%). Some patients reported drinking yoghurt and dairy products 
(13.31%) as they were easy to swallow. 
 
5.4.2 Appetite when using methamphetamine 
 
The majority (80.2%) reported a poor or very poor appetite when using 
methamphetamine (Table 5).   
 
Table 5: Appetite when using methamphetamine  
 
APPETITE  n % 
Very good 1 0.32 
Good 8 2.60 
Normal 52 16.88 
Poor 115 37.34 
Very poor 132 42.86 
Total 308 100.00 
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5.5 Perception of oral health risks associated with drug abuse 
 
Nearly all (95.45%) agreed that methamphetamine can damage their teeth and the 
most common perception (28%) was that ‘teeth will break’ when using 
methamphetamine. Almost a fifth (19.31%) reported that it will “eat” the teeth and the 
rest of participants indicated that teeth will rot, become brittle or crack. Some 
mentioned that methamphetamine causes cavities and the acid in the drug will damage 
teeth. 
 
5.6 Dental History 
 
5.6.1 Perception on appearance and functionality of teeth 
 
The majority (63.31%) of the sample were not satisfied with the appearance of their 
teeth, but more than half (53.57%) were satisfied with the functioning of their teeth.  
 
5.6.2 Last dental visit 
 
The majority (56.17%) reported that their last dental visit was more than a year ago 
and 27.27% reported visiting a dentist in the last 6 months (Table 6).  
 
Table 6: Last dental visit 
 
LAST DENTAL VISIT n % 
In the last 6 months 84 27.27 
About a year ago 40 12.99 
More than a year ago 173 56.17 
Never 11 3.57 
Total 308 100.00 
 
 
The most common reason for the last dental visit was due to a toothache (60.71%) 
(Table 7). The most common treatment  received during their last dental visit was a 
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dental extraction (72.47%). Other procedures, such as restorations (fillings) (9.76%) 
and cleaning (8.71%) were less common (Figure 7).   
 
Table 7: Reason for going to the dentist the last time 
 
 REASON FOR GOING TO DENTIST THE LAST TIME  n % 
Toothache 187 60.71 
Check-up 26 8.44 
Required fillings 21 6.81 
Chipped teeth 16 5.19 
Required cleaning 12 3.9 
Required dentures 6 1.94 
Bad breath 3 0.97 
Skew teeth 3 0.97 
Wisdom teeth 2 0.65 
Loose teeth 1 0.32 
No reason provided 31 10.06 
Total 308 100.00 
 
 
 
 
Figure 12: Last dental treatment received 
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5.6.3 Self-reported changes of teeth after period of abuse 
 
The majority (82.74%) of the participants indicated that their teeth had changed since 
they have started using methamphetamine.  
 
The majority of users reported that their teeth had broken (30.80%) and had become 
rotten (17.54%). A few users reported that their teeth had become weaker (3.79%) 
or/and chipped (3.79%).       
 
Slightly less than 17% of users who had experienced a change in their teeth reported a 
change in colour. Two thirds of the users who reported tooth discoloration indicated 
that their teeth had stained yellow and 13.95% reported a brown discoloration (Table 
8).   
 
Table 8: Tooth discolouration among methamphetamine users  
 
COLOUR  n % 
Yellow 29 67.44 
Brown 6 13.95 
Black 5 11.63 
Blue 1 2.33 
Off-white 1 2.33 
White spots 1 2.33 
Total 43 100.00 
 
5.7 Oral health symptoms experienced during methamphetamine use 
 
The majority of participants (93.51%) reported that they had a dry mouth and a bad 
taste in their mouth (91.23%) when using the drug (Figure 13). Almost three quarters 
(73.38%) reported stiff facial muscles and more than half (59.74%) said that they 
were grinding their teeth. Other symptoms that were less common included sore gums 
(33.44%) and a “burning” sensation in the mouth (21.1%). There was an association 
between grinding teeth and stiff facial muscles (p = 0.00024; RR = 1.3). Females were 
1.5 times more likely to have sore gums compared to males (0.013).  
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Figure 13: Oral symptoms experienced during usage of methamphetamine 
 
5.8 Effect on saliva secretion 
 
5.8.1 Duration from start using methamphetamine until experiencing a dry mouth  
 
The majority (93.52%) indicated that the duration from the time they started using 
methamphetamine until they experienced a dry mouth was less than an hour. Almost a 
third reported that their mouth was dry within 5 minutes (Table 9).   
 
Table 9:  Time from using methamphetamine until experiencing a dry mouth 
 
Time until dry mouth All participants Females Males 
≤ 5 minutes 30.72% 36.96% 27.86% 
> 5 min ≤ 60 min 62.80% 54.35% 66.67% 
> 1h ≤ 6 h’s 5.80% 7.61% 4.98% 
> 6 h’s  0.68% 1.09% 0.50% 
Total 100% 100.00% 100.00% 
 
5.8.2 Time from the last dosage until the user experienced a normal salivated 
mouth 
 
Three quarters of the sample indicated that the time for their mouth to return to 
‘normal’ again after the last dosage of methamphetamine was 5 minutes to 1 hour 
(Table 10). 
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Table 10:  Time from last dosage until experience normal salivated mouth 
 
Time until normal All participants Females Males 
> 0 ≤ 60 min 6.14% 10.87% 3.98% 
> 1 ≤ 24h’s 77.82% 75.00% 79.10% 
> 1 ≤ 7 days 14.33% 11.96% 15.42% 
> week 1.71% 2.17% 1.49% 
Total 100% 100% 100% 
 
5.9 Brushing frequency 
 
Tooth brushing was regarded as frequent when occurring twice or more per day and 
infrequent when occurring once or less per day. The period when the individual were 
using methamphetamine was titled as “On Meth” and not using methamphetamine 
was “Off  Meth” (Table 13).     
  
5.9.1 Brushing frequency when not using methamphetamine 
 
The majority (82.47%) of participants reported that they brushed their teeth either 
once or twice a day when not using methamphetamine. Almost half (48%) brushed 
their teeth frequently (Table 11). 
 
Table 11: Brushing frequency when not using methamphetamine 
 
TEETH BRUSHING FREQUENCY n % 
Never 2 0.65 
Less often 32 10.39 
Once a day 126 40.91 
Twice a day  128 41.56 
More often  20 6.49 
Total 308 100.00 
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5.9.2 Brushing frequency when using methamphetamine  
 
Nearly half reported that they brushed their teeth less than once a day or never when 
using methamphetamine. Slightly more than a third (37.99%) of the sample were 
brushing their teeth frequently during stages of drug use (Table 12). 
 
Table 12:  Brushing frequency during drug use 
 
BRUSHING FREQUENCY DURING DRUG USE n % 
Never 17 5.52 
Less often 110 35.71 
Once a day 64 20.78 
Twice a day 51 16.56 
More often 66 21.43 
Total 308 100.00 
 
 
There was a significant difference in teeth brushing frequency when using 
methamphetamine (“On Meth”) compared to not using the drug (“Off Meth”) (p = 
0.0000022; χ2 = 23.84). Only a quarter of the sample was brushing frequently 
during periods of “On Meth” and “Off Meth”. The majority (40%) of the sample 
was brushing infrequently irrespective of being “On” or “Off” the drug (Table 13).  
 
Table 13: Brushing frequency during ‘Off’ and ‘On’ Meth use 
       
 
 
 
 
 
 
 
 
   Off Meth 
 
 
 
Frequent  Infrequent  Total 
 
On Meth 
Frequent 77 40 117 
Infrequent 71 120 191 
 TOTAL 148 160 308 
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5.10 Medical history 
 
The majority (79.55%) was medically healthy and on no medication (82.79%). The 
most common self-reported medical condition was a “mental disorder” and nearly a 
quarter reported they were suffering from a respiratory condition (Table 14).  
 
Table 14: Common categories of medical conditions 
 
COMMON MEDICAL CONDITION (CATEGORY) n % 
Mental  32 55.17 
Respiratory 14 24.14 
Cardiovascular 7 12.07 
Metabolic 3 5.17 
Auto-Immune 2 3.45 
Total 58 100.00 
 
 
Bipolar disorder and depression was the most common mental disorders among users 
of methamphetamine. Other mental disorders included depression, schizophrenia, 
anxiety, psychosis and ADHD (Table 15). 
 
Table 15: Most common mental disorders among methamphetamine users 
 
MENTAL DISORDERS n % of sample 
Bipolar 11 3.57 
Depression 9 2.92 
Schizophrenia 7 2.27 
Anxiety 3 0.97 
Psychosis 3 0.97 
ADHD 1 0.32 
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5.11 Dental Caries Status 
 
Almost the entire sample (98.05%) was affected by dental caries and the mean DMFT 
score was 10 (Figure 14). Most users had 2 – 4 decayed teeth. The mode for DMFT 
was 8 and the mode for sound teeth was 19. Eight (2.6%) users were caries-free and 
one user had 21 decayed teeth. More than half of the sample (55.97%) had a DMFT 
score of 0 – 14. Almost a fifth of the sample had a DMFT score of 15 – 21 (Table 16). 
The majority of participants (90.58%) had a DMFT score of 4 and more (95% CI: 
86.62% - 93.5%). The mean number of filled teeth was one and the mean number of 
missing teeth per person was five. Fourteen per cent (14%) of the sample had 10 and 
more teeth missing. Three users (1%) were completely edentulous. The mean number 
of decayed permanent teeth per patient was 5 and the majority of the sample (89.29%) 
had untreated decayed teeth (95% CI: 85.15% - 92.41%). 
 
Table 16: DMFT-scores of methamphetamine users  
 
DMFT n % 95% CI 
0 – 7 101 32.79% 27.62% - 38.39% 
8 – 14 133 43.18% 37.61% - 48.93% 
15 – 21 61 19.81% 15.59% - 24.79% 
>21 13 4.22% 15.59% - 24.49% 
Total 308 100.00%  
 
 
Figure 14: DMFT distribution of methamphetamine users 
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Table 17: Dental status of methamphetamine users  
 
 Mean SD 
Decayed Teeth 5 3.71 
Filled Teeth 1 2.04 
Missing Teeth 4 4.92 
DMFT 10 5.87 
 
 
Figure 15: DMFT and duration of addiction 
 
Table 18: Duration of addiction vs DMFT 
 
Duration of addiction n Mean DMFT Variance SD % 
1 - 4 years 98 8.52 23.86 4.88 31.82 
5 - 8 years 131 11.26 37.12 6.09 42.53 
9 - 12 years 74 11.01 33.68 5.80 24.03 
> 12 years 5 11.2 128.7 11.34 1.62 
Total 308 10    
 
 
There was an association between mean DMFT and duration of addiction (p = 0.003). 
Users who were using methamphetamine for the shortest duration of time had a lower 
DMF score of 8 compared to those who were using methamphetamine for longer than 
4 years who had a DMF score of 11. 
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Users who were using methamphetamine for the shortest duration of time had less 
teeth decayed (3) compared to those who were using methamphetamine for longer 
than 4 years who each had 5 teeth decayed.  
 
The association was less significant when mean number of missing teeth and duration 
of drug addiction was compared (p = 0.04). Users who were using methamphetamine 
for the shortest duration of time, had less teeth missing (3) compared to those who 
were using methamphetamine for longer than 4 years who had 5 teeth missing each. 
 
5.12 Dental treatment required after clinical examination 
 
The most common dental treatment required was extraction.  One fifth of the sample 
required at least 1 extraction while 13% required at least two extractions. The mean 
number of extractions required per user was 2 teeth.  One user, who was smoking 
methamphetamine for 13 years, required 19 extractions.  
 
The highest level of education which was achieved by users was associated with the 
least number of extractions which were required (p = 0.003). There was a significant 
(p-value = 0.005517) difference observed between the education groups with regards 
to the number of extractions that were required. Figure 16 is a plot of mean number 
extractions required against level of education. Users who reached tertiary level of 
education were significantly different in terms of number of extractions which were 
required compared to those who reached high school. Users who reached primary 
school compared to those who reached high school were marginally different.  
 
 
Figure 16: Extractions required according to level education  
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5.13 Summary 
 
The most prominent findings from the study were that most users are male, 
unemployed and the mean age was 28. The mean DMFT score was 10 and the last 
dental visit was more than a year ago.  A dental extraction was the most common 
treatment required by users and the most common oral symptoms were a dry mouth 
and a bad taste in the mouth. Users were brushing less frequently when they were 
using methamphetamine compared to when they were not using the drug and tooth 
brushing frequency was associated with duration of addiction. The level of education 
was associated with number of extractions required. Half of all users, whom had a 
medical condition, reported having a mental disorder. 
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CHAPTER 6: DISCUSSION AND CONCLUSION 
 
6.1 General  
 
The purpose of the present study was to determine the impact of Methamphetamine 
abuse on oral health.  
 
The present study found that methamphetamine users have serious health problems 
which include mental conditions, severe dental caries and extensive tooth loss. This 
concurs with other studies which had shown that methamphetamine has become a 
major problem in the United States (Rawson et al., 2002; Roehr, 2005), South Africa 
(Morris & Parry, 2006), and within the Southeast Asia and Pacific region (Farrell et 
al., 1992; Topp et al., 2002).  
 
6.2 Demographic information  
 
The South African Community Epidemiology Network on Drug Use (SACENDU) is 
a sentinel surveillance project operational in all nine provinces and monitors alcohol 
and drug use on a 6-monthly basis. The present study reflects similar demographic 
characteristics as reported by SACENDU: the majority of users are male, unemployed 
and in the age group 25-29 years. These demographic characteristics are similar to 
studies carried out in Australia (McKetin, 2006) and in the United States (Shrem & 
Halkitis, 2008).  
 
Poverty, unemployment and a lack of income are serious problems among 
methamphetamine users (Dada et al., 2013).  In the present study unemployment was 
72%. Henkel (2011) found that unemployment was a risk factor for substance use and 
that the problematic use of illicit drugs can increase the risk of unemployment 
(Henkel, 2011).   
 
In the present study, most of participants had reached high school but had not 
obtained a senior certificate. Low levels of education were associated with increased 
numbers of extractions and poor oral health.   
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6.3 History of abuse and habits  
 
The finding that users were smoking the drug either on a daily basis or more regularly 
was consistent with the literature (Dada et al., 2013; Mcketin et al., 2006).     
     
Nearly a fifth of the participants were introduced to the drug by their family whereas a 
study from the United States reported that only 10% of methamphetamine users were 
introduced to the drug by their family (United States Department of Justice, 1999).  
 
6.4 Dietary habits and appetite  
 
Studies have reported that most methamphetamine users have a poor appetite (Shaner, 
2006) and their diet usually included large quantities of soft drinks and alcoholic 
beverages (Brand et al., 2008; Shekarchizadeh et al., 2013). The present study found 
similar dietary habits of frequent intake of carbonated drinks and a poor appetite.  
 
6.5 DMFT and dental caries among methamphetamine users 
 
The mean DMFT score of the sample was 10 and dental status worsened with 
increasing duration of the addiction. These findings are similar to those supported in 
the literature (Shetty et al., 2010; Shaner, 2002; Klasser & Epstein, 2006; Morio et al., 
2008; Goodchild & Donaldson, 2007; Marshall, Qian, & Morgan, 2008; Cunningham, 
2011).  
 
6.6 Oral health status  
 
Participants complained of the poor dental appearance and functioning caused by  the 
deleterious effects of methamphetamine due to  rampant caries and multiple tooth loss 
leading to edentulism.  
 
The presentation of dental caries and demineralization patterns among study 
participants reflected the classical caries pattern of “Meth Mouth” (Hamamoto & 
Rhodus, 2009; Shaner, 2002). Cavities were found on buccal smooth surfaces and 
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interproximal areas of anterior teeth. Some researchers have reported that “Meth 
Mouth” appeared similar to the caries pattern observed in Sjogren’s syndrome 
(Rhodus & Little, 2005) and Early Childhood Caries (Shaner, 2002; Shaner et al., 
2006). “Meth Mouth” can be explained by the chronic dry mouth (Rhodus & Little, 
2005; Shaner, 2006), inadequate brushing and high sugar consumption.  
 
6.7 Oral health symptoms 
 
The present study had found that a dry mouth was the most common symptom 
experienced by users and this concurs with the literature (McGrath & Chan, 2005; 
Shaner, 2002, Hamamoto & Rodus, 2008). Activation of alpha-adrenergic receptors 
lead to vasoconstriction of the vasculature of salivary glands and decreased saliva 
secretion (Saini et al., 2005). An anticholinergic action causes a dry mouth which 
leads to difficulties with speaking and swallowing, an unpleasant taste sensation and 
burning mouth symptoms (Vidović Juras et al., 2010). It also leads to a sore mouth 
(Macknelly & Day, 2009), an inflammatory response of intra-oral soft tissue and 
related fungal infections such as candidiasis, resulting in cheilitis and glossitis (Heng 
et al., 2008). It was interesting to note that participants regarded a dry mouth as an 
indication of reaching a “high”. Most users reported that the time that elapsed from 
the last use of the drug until experiencing a ‘normal’ mouth was about 24 hours which 
concurred with literature (Lake & Quirk, 1984).  
 
Another common symptom experienced by participants was grinding of teeth which is 
also consistent with other studies (Goodchild & Donaldson, 2007; Turkyilmaz, 2010; 
McGrath & Chan, 2005).  A “bad taste in the mouth” while using methamphetamine 
was also reported but this finding could not be substantiated by other studies.   
 
Although dental pain was not always prominent during times of methamphetamine 
usage, participants did indicate they often had episodes of tooth ache during 
abstinence and the severity of the pain resulted in relapsing by using 
methamphetamine to bring pain relief. Less common symptoms included stiff facial 
muscles and constant grinding of teeth, “burning” sensation in the mouth and sore 
gums.  
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6.8 Risk factors for dental destruction 
 
The severe destruction of dentine and enamel can be explained by a chronic dry 
mouth, constant grinding of teeth and an increased consumption of carbonated soft 
drinks and snacks containing high levels of sugar and a poor appetite (Ravenel et al., 
2012). There is strong evidence to support the association between a dry mouth and 
risk for dental caries due to a decreased buffering effect (Garcia-Godoy & Hicks, 
2008). Other contributing factors can be an increased metabolism and physical 
activity (Shaner, 2002; Goodchild & Donaldson, 2007).  
 
6.9 Brushing frequency  
 
Brushing frequency during “On” and “Off” Meth usage was significantly different 
and this finding was in contrast to Cunningham et al., (2011) and Qian (2011). 
However these studies had significantly smaller sample sizes. Others have reported 
that methamphetamine users were found to rarely brush their teeth (Morio et al., 
2008) and  experienced irregular periods of oral hygiene (Hamamoto & Rhodus, 
2007) which is consistent with present study.   
 
6.10 Frequency of dental visits and treatment history   
 
Shetty et al. (2010) had found that methamphetamine users delay their dental visit 
until they have an acute episode of dental pain. This kind of behavior makes it very 
challenging to arrange follow-up visits with rehabilitative treatment and oral health 
promotion and education initiatives. In many instances, due to the high levels of 
dental destruction, complex restorative and surgical management is usually required 
to ensure complete oral rehabilitation of methamphetamine users. The present study 
found that users made infrequent dental visits and mainly for pain. Most users had 
their last dental visit more than a year ago and in most occasions, a dental extraction 
was the treatment received.   
 
Another reason for non-attendance could be related to the fact that users may not have 
dental insurance and a fragmented oral health care system which cannot deliver basic 
oral health care may contribute to an increasing unmet need (Shetty et al., 2010).  
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Furthermore, it has been reported that users often have financial constraints and are 
unable to afford  complex dental treatments that may be required (Klasser & Epstein, 
2005; Williams & Covington, 2006). 
 
6.11 Medical history 
 
Of those users who had an underlying medical condition, half of them reported having 
a mental disorder. Davidson et al. (2001) found that psychosis and paranoia are 
adverse effects of chronic Methamphetamine abuse that can last for years even after 
ceasing the drug abuse habit (Davidson et al., 2001). Pharmacological and 
physiological adverse effects have been implicated in permanent changes to 
neurological processes, and result in violent behavior, high risk sexual activities 
(Marshall  & Werb, 2010) and a detrimental effects on oral health (Goodchild & 
Donaldson, 2007). 
 
6.12 Conclusion 
 
Oral health care is required for the majority of clients at substance addiction treatment 
centres but due to financial constraints, many are not able to receive proper care. 
Methamphetamine abuse results in multiple physical, mental and oral health 
problems. Users are partly responsible for their oral health problems associated by 
substance addiction because of neglected self-care (Affinnih, 1999) and postponement 
of treatment until they experience severe symptoms and when the disease has reached 
an advanced stage (Robinson et al., 2005; Santolaria-Fernandez, 1995).     
 
Users often present with poor oral hygiene, severe adverse effects on hard and soft 
oral structures and consequent  pathological changes  Inadequate tooth brushing, 
hyposalivation, bruxism, a poor diet and an increased consumption of sugar-
containing beverages are the  main contributing risk factors.  
 
People with a history of methamphetamine addiction are complex to manage when 
they attend for dental care due to the severe dental destruction. The duration of 
exposure to methamphetamine is related to the number of teeth that are decayed, 
missing and filled. Brushing frequency is often low among patients with 
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methamphetamine addiction. The addictive nature of methamphetamine and a lack of 
support for the user could prolong recovery and rehabilitation.        
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CHAPTER 7: RECOMMENDATIONS  
 
7.1 General recommendations for staff at specialized substance abuse treatment 
centres  
 
Oral health rehabilitation is not included as a part of rehabilitation programmes for 
recovering drug addicts. In view of the fact that the oral health impacts are great, the 
introduction of oral health initiatives should form part of the general drug addiction 
rehabilitation programmes.       
 
Prevention of tooth decay should include:   
 
1. Oral health education and instructions given by staff and visiting oral health 
professionals  
2. Salivary substitutes which are available at pharmacies 
3. Chewing sugarless gum  
4. Increase intake of water (8 to 10 glasses of water a day) 
5. Increasing fluoride supplementation by administering a neutral fluoride  
6. Encourage the patient to reduce intake of sugary and carbonated drinks 
7. Avoid consumption of caffeine, tobacco and alcoholic beverages because of 
their diuretic effects  
8. Refer to dentist if patient presents with oral health problems  
9. Brushing teeth twice a day with fluoridated tooth paste  
 
7.2 Dental management 
 
Dental patients who disclose illicit drug use should be referred to a physician or 
substance abuse rehabilitation centre for further investigation. Dentists need to be 
aware of the clinical presentation and medical risks presented by patients who are 
using methamphetamine (Hamamoto & Rodus, 2009).  
 
Oral health professionals can play a crucial role in the early detection of 
methamphetamine abuse. An unusual caries appearance which reflects “Meth Mouth” 
should alert the clinician to investigate whether the patient are involve in any illicit 
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drug use. Furthermore, dentists may be the front-line healthcare workers recognizing 
the oral signs and symptoms of methamphetamine abuse. Therefore they need to be 
aware of the clinical presentation and medical risks presented by patients who are 
methamphetamine users.  
 
Dentists should be aware that all patients need to be handled sensitively and 
effectively. Important management issues include a good history taking of the medical 
problems, dental problems and behavioural problems.  
 
Establishing a good pre-treatment rapport with the patient will assist the dentist in 
reducing the need for postoperative analgesics, and will encourage this group of 
patients to return and obtain needed dental care. Restoring the dental appearance of 
patients recovering from methamphetamine may help them regain self-esteem.  
 
Initial dental management should include: 
1. Recognition of classical features & symptoms, encourage to stop the habit  
2. Address pain and infection   
3. Oral health education and instructions  
4. Refer patient to physician or substance abuse rehabilitation centre 
5. Diet analysis 
6. Professional fluoride application  
7. Restore and maintain oral health 
 
More attention should be given to dental caries prevention to support users during 
recovery and to educate those who might be at danger. Collaboration between oral 
health care providers and substance abuse treatment centres is required to address the 
problem of substance abuse.  
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 Appendix 1:  Questionnaire for methamphetamine study Record no. Date Venue In/Out Pt 
   
        
 
Demographic Information            
1. Patient's initials   
   
  
2. The first letter of the patient’s surname           
       
3. Birthdate (Age)         Year      Month      Day 
 
      
Age  
 
        
 
  
  
          
4. Place of birth 
     
       5. Are you currently married? Yes   
 
No   
6. Gender Male   
 
Female   
 7. 
  
  
  
  
 a. Do you have any children?  Yes   
 
No 
  b. If yes, how many children do you have?      
  8. 
If yes and female, Did you become pregnant 
before 20? Yes    No   
9. In which neighbourhood do you stay?     
 
    
10. Are you currently employed? Yes      No   
       11. What kind of work do you do?           
12. 
If no, how long have you been unemployed? 
a.Years      
   
 
b.Months  
     
 
 
Drug history 
13. At what age did you start using "tik”?     
   
14. How long ago did you use tik (days)? 
 
  
 
  
 
 a. Duration of addiction (years)?           
15. How often did/do you use "tik"? Everyday   
   
  
Weekly   
   
  
Monthly   
   
  
Yearly   
   
  
Other   
   16. 
 
Inject Snort Drink Smoke Other 
a. How did you use tik?           
b. What is the cost of a daily "dose" of 'tik' to:      
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17. 
Please indicate the amount (grams) of tik that 
you mostly use to buy per day.    0 - 1g 
 
1.1 - 2g 
 
2.1 - 
3g 
  
  
 
  
 
  
       
  
3.1 - 4g 
 
4.1 - 5g 
 
> 5g 
       
       
18. 
Did you use the above-mentioned amount all by 
yourself? Yes   
 
No   
  a. How long did it take to finish? < 24 hours 1 -7 days 2 - 4 weeks 
2 - 6 
months Longer 
       
  b. 
If no, how many people did you share the tik 
with?  1 person 2 - 5 people > 5 people 
  
 
 
       
  
19. 
Have you ever gone to a drug rehabilitation 
centre? Yes   
 
No   
a. If yes, how many times were you admitted? Once Twice More 
  
  
      
  b. Are you smoking tobacco (cigarettes) Yes   No 
 If yes, how many per day?      
 
Diet history 
     
20. 
Describe what you mostly drink  when you use 
tik:           
 
(e.g., Water, Soft Drinks, Beers, Brandy, Wine, 
Juice or           
 
something else, please explain   
   
  
21. What was the reason/s for having these drinks?           
  
          
22. 
How many of these drinks would you have? 
Per day   
   
  
(a) Per week           
23. 
Describe what you  were eating when you used 
'tik':           
24. What was the reason/s for eating these foods?           
25. 
How was your appetite (eating and drinking) 
when you were using 'tik'?  very good   
   
  
good   
   
  
normal   
   
  
poor   
     very poor     
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26. Where did you first hear of 'tik'? Family   
   
  
Friends   
   
  
TV   
   
  
Newspaper   
   
  
Radio   
   
  
School   
   
  
University     
 
  
Other 
    
       
       
27. 
What were your reasons to start using 
"tik"?      
  
 
Stress, boredom, to lose weight ….      
  
  
   
  
  
   
  
  
   
  
  
      
 
   
      
 
   
      
 
   
      
 
 
 
Dental history 
     
       
28. How often do you brush your teeth? never less often 
once a 
day 
twice a 
day 
more 
often 
  
          
       
29. 
Do you think that drugs e.g. Tik can 
damage your teeth?    Yes    
 
No   
 a. If yes, how will it damage your teeth?      
       
 
 
30. 
 
 
When was your last dental visit? Last 6months 
 
 
1 year ago 
> 1 year 
ago never 
 
       a. Why did you go to the dentist?  
       
b. Was any treatment done? Yes   No  
       
31. 
If yes, what was the treatment that was 
done?         
 
 
32. 
Are you satisfied with the appearance 
of your teeth? Yes    
 
No   
  a. If no, why not?     
3. 
Are you satisfied with the functioning 
(chewing ability) of your teeth?   Yes   No  
a. If no, why not?      
 
When you are using tik............. 34 - 41 b 
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34. 
Do you experience that you grind your 
teeth?  Yes    
 
No   
35. 
Do you experience any tightening or stiffness 
in your facial muscles? Yes    
 
No   
36. 
Do you ever experience a bad taste in your 
mouth? Yes    
 
No   
      
37. How often do you brush your teeth? never less often 
once a 
day 
twice 
a day 
more 
often 
 
            
      
38. Do you experience dental pain? Yes   
 
No   
39. Do you experience sore gums? Yes   
 
No   
40. 
Do you experience a burning sensation in 
your mouth? Yes   No  
       
41. Do you experience a dry mouth? Yes   
 
No 
 
a. 
If yes, how long (time) after you start using 
tik, does your mouth become dry, please be 
specific   ≤ 5 minutes 
> 5 ≤ 60 
min  
> 1h  
≤ 6 
h's 
> 6 
hours  
  
          
 
b. 
If yes, how long (time) after you stopped using tik, does your mouth go back to normal 
(not dry) again (please be specific) 
  
  
 > 0 ≤ 60 min  
> 1 ≤ 
24h's  
> 1 ≤ 
7days  
> 
7days  
     
       
42. 
Have your teeth changed in any way since 
you started using tik? Yes   
 
No   
      
 a. If yes, in which way did your teeth change?           
 
Please explain           
43. 
Please indicate highest level of education 
reached: No school         
  
Primary 
school         
  
High school         
  
Tertiary 
(College, 
University)         
 
Medical history 
     46. Do you suffer from any medical conditions? Yes  
 
No  
a. If yes, what are they?      
  
  
      
  47. Are you taking any medication? Yes   No 
(a) If yes, what medication are you taking?      
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Appendix 2: Data capture sheet 
 
 
         
Examiner No.  Centre Code 
   
                                                                                                                    
 
Age   
Gender (1 = Female, 2 = Male)   
Race (1 = W, 2 = C, 3 = A, 4 = B)   
 
 
Name   Date of Examination       
    Y Y M M D D 
CARIES STATUS AND TREATMENT NEEDS 
 
    55 54 53 52 51 61 62 63 64 65    
 18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
Status                 
Treatment                 
                 
Status                 
Treatment                 
 48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
    85 84 83 82 81 71 72 73 74 75    
STATUS  TREATMENT 
Permanent tooth Primary tooth      
0 = Sound A 0 = None 
1 = Decayed B 1 = Caries arrest. or sealant care 
2 = Filled & decayed C 2 = 1 Surface filling 
3 = Filled, no decay D 3 = 2 or more surface filling 
4 = Missing due to caries E 4 = Crown or bridge abutment 
5 = Missing any other reason  5 = Bridge element 
6 = Sealant, varnish F 6 = Pulp care 
7 = Bridge abutment or special crown  7 = Extraction 
8 = Unerupted tooth  8 = Need for other care  
9 = Excluded tooth  9 = Specify ………...................... 
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Appendix 3: Calibration of dental status measurement 
 
Pt No. Gold Sound + 
Exam Sound (a) 
Gold Sound + 
Exam Carious (b) 
Gold carious + 
Exam Sound (c) 
Gold Carious + 
Exam Carious (d) 
Total 
Pt 1 7 0 0 3 10 
Pt 2 12 2 0 2 16 
Pt 3 13 1 1 4 19 
Pt 4 27 0 0 1 28 
Pt 5 22 2 0 1 25 
Pt 6 20 1 0 7 28 
Pt 7 22 2 0 1 25 
Pt 8 14 0 0 2 16 
Pt 9 13 0 0 2 15 
Pt 10 11 1 1 7 20 
Pt 11 5 0 0 4 9 
Pt 12 23 0 0 5 28 
Pt 13 16 0 0 10 26 
Total 205 9 2 49  
      
FREQUENCIES  
  Gold Standard   
   Sound Carious Total  
 Sound 205 2 207  
Researcher Carious 9 49 58  
 Total 214 51 265  
      
 
PROPORTIONS 
 
  Gold Standard   
 Sound Carious Total  
 Sound 0.77 0.01 0.78  
Researcher Carious 0.03 0.18 0.22  
  0.81 0.19 1.00  
      
Observed 0.9585  Kappa Agreement  
Expected 0.6729  >0.8 Good  
Kappa 0.8731  0.6 - 0.8 Substantial  
   0.4 - 0.6 Moderate  
      
Agreement between Gold Standard and Researcher is Good  
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                                                                                             23 October 2011 
To whom it may concern 
 
This is a letter to elicit your support in a cross-sectional study that will be conducted 
to investigate the effects of Methamphetamine abuse on the mouth.   
 
The oral clinical picture of TIK abuse is termed “meth mouth” and can be explained 
by contributing factors such as dry mouth, a poor appetite and ability of acidic 
vapour of the drug to demineralise enamel. Dentists and other health care workers 
are in the front-line regarding the diagnosis and recognition of the oral signs and 
symptoms of someone who is addicted to Methamphetamine. Primary detection can 
contribute to early intervention and prevention of further use. 
 
A cross sectional study will be conducted at the Tygerberg Oral Health Centre and 
various Substance Addiction Centres in Cape Town. A structured questionnaire will 
be administered to elicit demographical details, drug use, diet, dental history, and 
employment status, level of education and awareness of the oral health risks 
associated with drug use. Clients who used Methamphetamine as a primary drug of 
choice will be randomly selected to participate.  
 
Participation will be on voluntary basis and their identity will remain anonymous at 
all times. A signed informed consent form will be obtained from all participants and 
they will have the right to withdraw from the study at any stage and this will not 
prejudice the patient in any future treatments.  
 
The clinical part of study will include an oral examination where their oral and 
dental status will be measured. This examination will l be non-invasive and will be 
an ideal opportunity to detect dental problems that require further management.  
The research proposal was given ethical clearance by the Faculty and Senate 
Research Ethics Committee of the University of the Western Cape. 
I would like to request a formal meeting with you to discuss your prospective 
participation in the study.    
 
Thanking you in anticipation 
Yours sincerely 
Dr Dirk A. Smit 
Registrar: Dental Public Health 
 
Appendix 4: Letter to treatment centre managers                   
Department of Community Oral Health 
Faculty of Dentistry & WHO Oral Health Collaborating Centre 
University of the Western Cape 
 
 
 
Private Bag X1, Tygerberg 7505 
South Africa 
Telephone: +27 21 937 3147 
Fax: +27 21 937 3182 
Email: dsmit@uwc.ac.za 
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Appendix 5: Informed Consent form 
Date: ......................................... 
Dear ……………………………………… 
I am a dentist and post graduate student from the Department of Community Oral Health at 
the University of the Western Cape. Regular use of Methamphetamine and other drugs can 
cause problems with the mouth and teeth and you are probably unaware of the risks 
associated with this habit. We are interested in interviewing you on regarding any drug 
habits that you may have to see if there are ways in which we can prevent any mouth 
problems from developing or help with any mouth problems you may have. 
The interview will take about 5 - 10 minutes. There are no risks in participating. We may take 
photographs, but only of your teeth and no-one will be able to see your face on the 
photographs.  All information gathered in the study will be treated as strictly confidential. 
No one will have access to this information except the researcher. Neither your name nor 
anything that identifies you will be used in any reports of this study. All information 
collected will be maintained and stored in such a way so as to keep it as confidential as 
possible. Your participation is voluntary and you may withdraw from the study at any time 
without any penalties.  
If you would like to take part in the study, please sign the bottom of this letter. If you would 
like to know anything more about the study, please contact Dr Dirk Smit on telephone 
number at work 021-937 3147. 
Thanking you in advance for your co-operation. 
Dr Dirk Smit 
------------------------------------------------------------------------------------------------------------ 
I understand what will be required of me to take part in the study. I agree to participate in 
the research being undertaken by Dr Dirk Smit. I understand that at any time I may 
withdraw from this study without giving a reason and without affecting my treatment in 
the future. 
 
Name:………………………………....…..                          …………………………….. 
(print in block letters)                                                (Signature) 
 
Telephone Number: ………………….                           ………………………………    
                                                                                          (Witness) 
Date: …………………………………........ 
Department of Community Dentistry 
Faculty of Dentistry & WHO Oral Health Collaborating Centre 
University of the Western Cape  
 
 
 
 
 
 
 
 
ity of the Western Cape 
 
 
 
Private Bag X1, Tygerberg 7705 
South Africa 
Telephone: +27 21 937 3147 
Fax: +27 21 937 3182 
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Appendix 6: Patient informed consent for photography 
 
UNIVERSITY OF THE WESTERN CAPE 
FACULTY OF DENTISTRY  
  
Patient Consent to Clinical Photography and 
Video Recordings 
Surname:  
Name:  
Date of Birth:                   Gender:  
I, .............................................................................................. consent to photographs or  
video recordings  being taken of me/my child as requested, I understand that these 
photographs and recordings will be stored appropriately, treated with the utmost 
confidentiality and be part of my dental record. I hereby give consent for the images or 
recordings to be used ONLY for the boxes I have indicated with a tick (√): 
□  Record purposes and for my/my child’s future management 
The photographic images and recordings will form part of the information collected 
for you or your child’s care and treatment. This information is handled in accordance 
with the HPCSA Booklet 14: Guidelines on the keeping of patient records. 
□  Education and training purposes 
The photographic images and recordings may be used for teaching purposes and 
viewed by health professionals outside of the UWC Faculty of Dentistry. The images 
may be used for example, in talks, conference presentations, posters or on the 
Internet to help train other health professionals in the management of dental and 
oral diseases 
□  Approved research purposes & publication 
  This may involve the photographic images and recordings being used for example in 
medical or dental publications, journals, textbooks, conference material, e-
publications and on the Internet. Images will be seen by health professionals and 
researchers who use the publications in their professional education. The images 
may be seen by the general public. Images will not be used with identifying 
information such as name, however, full confidentiality is not guaranteed. 
□  Other purposes (please specify): ………………………………………………. 
•  I understand that all efforts will be made to conceal my/my child’s identity but that 
full confidentiality cannot be guaranteed. 
• I understand that my consent or refusal will in no way affect my /my child’s dental 
care. 
Patient Signature: ................................................. ...      Date: .......................................... 
Parent/Guardian if patient under 18 years)  
Name: ........................................................................ 
Signature...................................................................      Date: ……….................................... 
Child assent (7-17 years):……………………………..…….......      Date: ……………………......................  
Witness Name & Signature.................................. .....       Date: …………………………................ 
 
 
 
 
